Objectives. Determine outcome of the 2005 appropriateness use criteria (AUC) for SPECT in a diverse population of patients and physicians. Background. AUC for SPECT were the first cardiology document to identify 52 clinical indications for imaging, 49 of them for stress SPECT. AUC have been proposed as cornerstone of responsible use of perfusion imaging. Methods. 585 consecutive patients undergoing SPECT were evaluated prospectively. Appropriateness was examined for demographic variables, clinical variables, and for physician and patient subgroups. Combined end-point of total mortality, cardiac revascularization, and cardiac admissions at 1 year post SPECT was evaluated. Results. SPECT indications were: appropriate, 63%; uncertain, 20%; inappropriate, 14%; not assigned, 3%. Most appropriate SPECT were observed in patients with known coronary disease (72%), chest pain syndrome (89%), high pre-test likelihood of disease (100%), men (70%), inpatients (72%), and cardiovascular physicians' referrals (69%). End-point was reached in 53 patients (97.4% follow up). Unadjusted event rates were: appropriate (12%), uncertain (7.1%), inappropriate (2.4%) SPECT (P = .01). Conclusion. Appropriateness of SPECT differs in subgroups of patients and physicians. Clinically significant outcomes occur more frequently in the appropriate stress SPECT group. Focused efforts are need for outpatients, asymptomatic patients, women, and non-cardiovascular physicians.
Introduction
There has been an explosive growth in cardiovascular imaging with stress testing demonstrating 6.1% annual increase versus 2% for cardiac catheterization, 0.8% for percutaneous intervention, and 0.1% for acute myocardial infarctions in population-based study of the United States Medicare patients from 1993 to 2001 [1] . Increased use of cardiac imaging has been under scrutiny with the Center for Medicare and Medicaid Services, and significant cuts to SPECT payment schedules were implemented under the Deficit Reduction Act in November 2009. Additionally, insurance payers contracted with radiation services benefit managers to oversee utilization of cardiac imaging further limiting access to imaging.
In response to these developments, the American College of Cardiology pioneered appropriateness criteria for single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) in 2005. The criteria were developed to account for evidence-based clinical relevance of stress perfusion imaging and were the first cardiologyspecific document to address appropriateness. The criteria relied on the modified RAND/UCLA methodology to identify 52 common clinical scenarios that were divided by level of appropriateness into appropriate, uncertain, and inappropriate indications [2, 3] . 49 indications addressed stress SPECT, 1 viability, and 2 radiocineangiography. Appropriateness criteria were subsequently developed for stress echocardiography, cardiac computed tomography, cardiac magnetic resonance imaging, and coronary revascularization [4] [5] [6] . SPECT criteria were reviewed in 2007 with new designations suggested for some indications [7] . An update on appropriateness criteria was published in May 2009 [8] .
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Appropriateness criteria became incorporated as a mandatory requirement by the Intersocietal Commission of Accreditation of Nuclear Laboratories starting in 2010. The American Recovery and Reinvestment Act of 2009 has endorsed a concept of comparative effectiveness that needs to be applied to cardiac imaging, and appropriateness criteria are expected to play a central role in that process [9] . In September of 2010, Center for Medicaid and Medicare Services has solicited an evaluation of point-of-order and point-of service determination of appropriateness in Medicare beneficiaries across a broad range of physicians and settings: SPECT MPI was the only cardiac procedure included. (http:// www.cms.gov/DemoProjectsEvalRpts/downloads/Medicare Imaging Demonstration.pdf). To encourage the best use of AUC and decrease inappropriate imaging, the ACC national quality initiative Imaging in "Focus" (http://www.cardixosource.org/Science-And-Quality/Quality-Programs/Imaging-in-FOCUS.asp) contains multiple resources pertaining to the AUC, including a decision algorithm has been developed by the ACC in partnership with Skyscape [10] . A free smartphone AUC application based on 2009 guidelines has been released (http://www.astellasapps.com/).
Despite these developments, the clinical use of the appropriateness criteria has not become standard of practice for physicians. Gibbons et al. have investigated performance of appropriateness criteria for stress SPECT and stress echocardiography in 284 and 298 patients, respectively [11] . Overall, 64% of stress studies were appropriate. 14% of SPECT and 18% of stress echocardiography studies were performed for inappropriate indications, and approximately 10% of all patients were unclassifiable. In a prospective multicenter trial, the appropriateness criteria were evaluated in 7 physician practices of various size in partnership with United HealthCare. Overall, 14% of all studies were inappropriate, most in asymptomatic individuals [12] .
The objectives of the current study were to identify clinical value of 2005 AUC in various patient and physician groups and to focus on downstream use of resources as defined by patient outcomes in relation to appropriateness. We have prospectively applied appropriateness criteria to a diverse population of patients and physicians to evaluate:
(1) impact of demographic (gender) and clinical (known coronary disease, symptoms, pretest likelihood, Framingham risk scores (FRS), and admission status) factors, (2) impact of referring physician specialty and practice type, (3) outcomes at 1 year after SPECT (combined endpoint of total mortality, coronary revascularization, or admission for cardiac reason other than revascularization). 
Methods

Physician Specialty Verification.
Referring physician name for each patient was cross-referenced with the hospital roster of credentialed physicians for both voluntary and fulltime faculty. All cardiology and cardiac surgery physicians were designated as cardiovascular (CV MD). All other physicians were designated as noncardiovascular (non-CV MD). There were 258 patients referred by CV MDs, and 327 referred by non-CV MDs.
Appropriateness Criteria.
Appropriateness criteria tables were included in each patient's file upon recruitment into the study [3, 13] . Appropriateness was determined prospectively based on symptoms, pre-test likelihood of disease [14] , Framingham risk scores, FRS [15] , and presence or absence of 49 stress SPECT MPI indications as identified during patient interview. While pre-test likelihood of disease was determined for all patients, FRS were estimated for asymptomatic patients without known coronary artery disease. The following assumptions were made.
(1) Lipid values were often not available for calculation of FRS. Total cholesterol and HDL cholesterol were assigned 0 points if no dyslipidemia or treatment with statins were reported, and 1 point if reported.
(2) Any chest pain syndrome or anginal equivalent were recognized as symptoms.
(3) If more than one indication was identified, the most appropriate for SPECT was chosen by consensus opinion of investigators.
Statistical Analysis.
Chi-square was used, and Fisher exact test was substituted for chi-square as indicated by frequencies of observations. SAS 9.1 (Cary, NC) was used for analysis.
Results
Patient Population.
Patient characteristics are presented in Table 1 . Overall, 570 (97%) of patients were assigned by appropriateness indications. Among 15 (3%) patients not classifiable 3 were inpatients, 12 were outpatients, 12 were men, 3 were women, 8 had known CAD, and 7 had no CAD. 7 unassigned patients were asymptomatic: 2 with a low FRS, and 5 with an intermediate FRS.
Two site-specific patterns of care are important to mention. Our emergency room policy expedites admission to the in-house hospitalist service for any patient with a "soft rule out MI", thus many of them were inpatients at the time of SPECT MPI. Additionally, despite a rather high number of patients with symptoms (53%), only 6% of patients were in the high pre-test category reflecting a bias toward invasive coronary angiography. 
Appropriateness of SPECT by Symptoms and Pretest
Likelihood. As expected, symptoms (Figure 2(a) ) and pretest likelihood of disease (Figure 2(b) ) significantly affected SPECT appropriateness. Appropriate studies were observed in 88% of patients with symptoms, in 96% of an intermediate pre-test likelihood group, and in 100% of a high pretest likelihood group. Most of the inappropriate SPECT were observed in asymptomatic and low pre-test likelihood patients (58/84 and 83/84, resp.). Most of the uncertain stress SPECT were also observed in asymptomatic and low likelihood patients (106/116 and 107/116, resp.). Pretest likelihood did not differ by gender or known CAD.
Appropriateness of SPECT in Asymptomatic Patients.
Asymptomatic patients without CAD were analyzed for stress SPECT appropriateness using FRS (Figure 3) . Of the 175 patients, 7 were not assigned by appropriateness criteria. In the remaining group of 168 patients, FRS were low in 56 (33%), intermediate in 96 (57%), and high in 16 (9%). Based on age and gender, 160 had low pre-test probability of disease, and 8 were in the intermediate probability group. Most high FRS patients had appropriate SPECT (88%), those with an intermediate FRS had mostly uncertain SPECT (74%), while patients with low FRS had mostly inappropriate SPECT (88%).
Appropriateness by Admission Status, Gender, and Known
CAD. Admission status, gender, and known CAD influenced SPECT appropriateness (Table 3) .
Admission Status.
In comparison to outpatients, inpatients were more symptomatic (65% versus 43%, P < .0001), and at a higher pre-test likelihood risk (low: 44% versus 57%, intermediate/high: 56% versus 43%, P = .02) but did not differ by gender, known CAD, or FRS. Most inpatients (66%) were referred by non-CV MDs (Table 2) . Most inpatients had appropriate stress SPECT studies (72%) with inappropriate SPECT similar to outpatients (15% and 14%, resp.). More uncertain SPECT (27% versus 13%) was observed in outpatients.
Gender.
Women had more symptoms (57% versus 49%, P = .04), and less known CAD (15% versus 39%, P < .0001) but did not differ in pre-test likelihood categories as compared with men. FRS were different for asymptomatic women as compared to men with more women in the low, and fewer women in the high risk groups: low, 41% versus 24; intermediate, 54% versus 61%; high, and 5% versus 15%, P = .01. Most women were referred by non-CV MDs (66%) with more even distribution among specialty of physicians for men ( Table 2) . As compared to men, women had less of appropriate SPECT (59% versus 70%) with nearly a threefold difference in inappropriate SPECT (22% versus 9%).
Known CAD.
Compared to patients without known CAD, patients with CAD had fewer symptoms (42% versus 58%, P = .0007). More men (39%) than women (15%) had known CAD (P < .0001). 72% of all known CAD patients were referred by CV MDs. Patients with known CAD had more appropriate SPECT (74% versus 61%), and the least of inappropriate SPECT (4% versus 19%, P < .0001).
Appropriateness by Physician
Specialty. There were differences in admission status, gender, and known CAD by referring physician specialty (Table 4) . Most inpatients (66%) were referred by non-CV MDs. As expected, the majority of patients with known CAD were referred by CV MDs (72%). More men than women were evaluated by CV MDs. CV MDs outperformed non-CV MDs (Table 5 ) with more appropriate, and less inappropriate SPECT referred (69% versus 62%, and 10% versus 18%, resp., P = .03). Among CV MDs, private practitioners had a trend for more appropriate SPECT than full-time faculty cardiologists (74% versus 63%) although this difference was not significant. As described above, more women and inpatients were referred by non-CV MDs while more men, outpatients, and patients with known CAD were referred by CV MDs.
Outcome Analysis by Appropriateness Category.
Follow up was completed in 554 patients: 359 with appropriate, 113 with uncertain, and 82 with inappropriate SPECT. Combined end-point of total mortality, revascularization and hospital admission for a cardiac reason other than revascularization was reached in 53 patients. There were 20 death (17 in appropriate SPECT patients), 14 revascularizations (13 in appropriate SPECT patients), and 28 admissions (21 in appropriate SPECT patients). Unadjusted events rates were 12% (43 of 359 patients) for appropriate, 7.1% (8 of 113 patients) for uncertain, and 2.4% (2 out of 82 patients) for inappropriate SPECT (P = .01).
Discussion
This study prospectively evaluated 2005 SPECT appropriateness criteria in a diverse patient and physician population from a large regional medical center. Overall, prevalence of appropriate (63%) and inappropriate (14%) SPECT was similar to those reported by previous studies [11] . The patient population was diverse: nearly equally representative of men and women, patients with or without CAD, inpatients and outpatients, and referred by private as well as fulltime faculty cardiologists and noncardiologists. Almost all patients were successfully assigned into an appropriateness category with only 3% not classifiable (Figure 1 ). Followup was complete in 97.4% of patients, and outcome analysis was undertaken for a combined end point of total mortality, cardiac revascularization, and cardiac admission for reason other than revascularization. Several important conclusions emerge from this study. First, appropriateness of SPECT was strongly influenced by presence of symptoms (Figure 2(a) ), pre-test likelihood of disease (Figure 2(b) ), and Framingham risk scores ( Figure 3 ). As may have been expected, there was a strong trend for more appropriate studies in symptomatic patients and those at a greater likelihood of CAD. Importantly, most inappropriate studies were observed in asymptomatic and low risk patients. These findings prove the robustness of criteria in clinical application. While specific scenarios may differ from institution to institution, the recognition of these general patterns in appropriateness criteria should be helpful to clinicians.
Secondly, findings emerged in patient subgroups that are interesting and require further investigation. As may be expected, inpatients were more symptomatic and at a higher clinical probability of coronary artery disease. Thus, it is not surprising that more appropriate SPECT studies were observed in inpatients. Appropriateness criteria appeared more favorable toward patients with established CAD.
Women were more symptomatic than men but did not differ in pre-test likelihood of disease and had a lower prevalence of known CAD. Among asymptomatic patients, more women were at a lower FRS. While less of appropriate SPECT was observed for women (59% versus 70% in men, Table 3 ), the most notable difference was in the occurrence of the inappropriate studies (22% in women versus 9% in men). It is likely that such a difference cannot be attributed solely to less prevalent CAD or lower FRS. These findings suggest a gender-related referral bias and indicate that it may be important to include gender-specific recommendations in the appropriateness criteria.
Another challenging group were asymptomatic patients in an intermediate FRS group (Figure 3 ). Most of them had uncertain SPECT (74%), some were appropriate (23%), and very few were inappropriate (3%). Performing SPECT in asymptomatic patients may not be warranted, and further studies are needed to determine merits of SPECT imaging in this patient subgroup. inappropriate, and those with uninterpretable ECG in the uncertain categories. Further discussion of the merits of SPECT MPI and other modalities in the asymptomatic patients is provided in the informational statements on http://asnc.org/imageuploads/Asymptomatic.pdf. There were notable differences by referring physician specialty. Cardiovascular physicians outperformed their noncardiovascular colleagues with more appropriate SPECT referred, although that difference was small (69% versus 62%). Importantly, significantly fewer inappropriate studies were referred by cardiovascular MDs (10% versus 18%, Table 5 ). These results may be reflective of a patient selection bias as more "appropriate" patients such as men, and those with known CAD were referred by cardiovascular physicians. However, significantly more inpatients (another "appropriate" group) were referred by noncardiovascular MDs. No significant differences were observed among private and faculty cardiologists. Further educational and consultative efforts are likely needed to increase appropriateness of referrals by noncardiovascular physicians.
Finally, outcomes differed significantly by appropriateness of SPECT. Unadjusted event rates were high for patients with appropriate SPECT (12%), lower for those with uncertain SPECT (7.1%), and lowest for the inappropriate SPECT patients (2.4%). A 7.1% event rate in the uncertain group suggests that it is prudent to perform these studies until factors or scenarios are identified that would allow to further risk stratify this group.
Limitations.
Notable limitations exist in this study. First, this represented a single medical center experience. As such, selection bias, referral bias, and practice preference bias were all present. Second, we have made assumptions in calculating FRS that may have affected appropriateness designations. Third, not all appropriateness indications were equally prevalent in our cohort, and some were observed in less than 1% of the patients. Fourth, we have not been able to evaluate cardiac mortality but rather a combined end point that included total mortality, revascularization, and cardiac admissions. Fifth, 15 of our patients remained unclassified. Most of them would have been assigned as uncertain if 2009 AUC were used, and not likely to affect appropriate and inappropriate groups.
Conclusion
We have established that appropriateness criteria are effective in identifying appropriateness of SPECT in a diverse patient population. More appropriate studies were observed in patients with symptoms and at higher pre-test likelihood and Framingham risk. Most of the inappropriate studies were observed in asymptomatic and low risk patients. 
